Specifically, disruption of the circadian clock pharmacologically (REV-ERB agonists) or genetically (CLOCK and BMAL1 short hairpin RNAs) impairs glioma stem cell (GSC) stemness in GBM and causes GSC cell-cycle arrest and apoptosis (17, 18). The gene discussed is CLOCK; the disease is central nervous system cancer.